Christopher J Sonnenday
Affiliation: University of Michigan
- Racial and geographic disparities in the utilization of surgical therapy for hepatocellular carcinomaChristopher J Sonnenday
The Department of Surgery, The University of Michigan, Ann Arbor, MI, USA
J Gastrointest Surg 11:1636-46; discussion 1646. 2007..001). Further investigation to understand the etiology of these profound racial and geographic disparities is essential to ensure equitable provision of surgical therapies, which provide the only potentially curative treatments for HCC...
- Analytic morphomics, core muscle size, and surgical outcomesMichael J Englesbe
Analytic Morphomics Group, Department of Surgery, University of Michigan Medical School, Ann Arbor, MI 48109 5331, USA
Ann Surg 256:255-61. 2012..Assess the relationship between lean core muscle size, measured on preoperative cross-sectional images, and surgical outcomes...
- Racial/ethnic disparities in access to care and survival for patients with early-stage hepatocellular carcinomaAmit K Mathur
Department of Surgery, University of Michigan, Ann Arbor, 48109, USA
Arch Surg 145:1158-63. 2010..To determine whether controlling for differences in the use of invasive therapy affects racial/ethnic differences in survival of early-stage hepatocellular carcinoma (HCC)...
- Frailty, core muscle size, and mortality in patients undergoing open abdominal aortic aneurysm repairJay Soong Jin Lee
Division of Transplantation, Section of General Surgery, Department of Surgery, University of Michigan Health System, Ann Arbor, Mich, USA
J Vasc Surg 53:912-7. 2011..We sought to use core muscle size as an objective measure of frailty, and determine its utility as a predictor of survival after abdominal aortic aneurysm (AAA) repair...
- Clinical yield of diagnostic endoscopic retrograde cholangiopancreatography in orthotopic liver transplant recipients with suspected biliary complicationsB Joseph Elmunzer
Division of Gastroenterology and Hepatology, University of Michigan Medical Center, Ann Arbor, MI 48109, USA
Liver Transpl 18:1479-84. 2012....
- Surgical site infection and analytic morphometric assessment of body composition in patients undergoing midline laparotomyJay S Lee
Center for Analytic Morphomics and the Summer Student Research Program, Department of Surgery, University of Michigan, Ann Arbor, MI, USA
J Am Coll Surg 213:236-44. 2011..Our hypothesis is that morphometric measures of midline subcutaneous fat will be associated with increased risk of SSI and will predict SSI better than conventional measures of obesity...
- Adverse outcomes in patients with chronic liver disease undergoing colorectal surgeryAmir A Ghaferi
Department of Surgery, University of Michigan, Ann Arbor, Michigan, USA
Ann Surg 252:345-50. 2010..We sought to use a multi-institutional, prospective, clinical database to better understand adverse outcomes in chronic liver disease (CLD) patients undergoing colorectal surgery...
- Portal vein thrombosis and survival in patients with cirrhosisMichael J Englesbe
Division of Transplantation, Department of Surgery, University of Michigan, Ann Arbor, MI, USA
Liver Transpl 16:83-90. 2010..39; 95% CI, 2.39-22.83). In conclusion, patients with cirrhosis complicated by PVT have an increased risk of death...
- Racial disparities in surgical resection and survival among elderly patients with poor prognosis cancerSha shonda L Revels
Center for Healthcare Outcomes and Policy, School of Public Health, University of Michigan, Ann Arbor, MI 48109, USA
J Am Coll Surg 216:312-9. 2013..Reports indicate that black patients have lower survival after the diagnosis of a poor prognosis cancer, compared with white patients. We explored the extent to which this disparity is attributable to the underuse of surgery...
- Sarcopenia and mortality after liver transplantationMichael J Englesbe
Department of Surgery, University of Michigan, Ann Arbor, MI, USA
J Am Coll Surg 211:271-8. 2010..Surgeons frequently struggle to determine patient suitability for liver transplantation. Objective and comprehensive measures of overall burden of disease, such as sarcopenia, could inform clinicians and help avoid futile transplantations...
- Is MRCP equivalent to ERCP for diagnosing biliary obstruction in orthotopic liver transplant recipients? A meta-analysisJennifer E Jorgensen
Department of Gastroenterology, University of Michigan Health System, Ann Arbor, Michigan 48109 5362, USA
Gastrointest Endosc 73:955-62. 2011..Endoscopic retrograde cholangiography (ERC) is considered the diagnostic criterion standard for post-orthotopic liver transplantation biliary obstruction, but incurs significant risks...
- Endoscopic access to and exploration of the lesser sac in a human cadaver model: opportunity for transgastric endoscopic pancreatic surgery (with video)B Joseph Elmunzer
Division of Gastroenterology, University of Michigan Medical Center, 3912 Taubman Center, SPC 5362, Ann Arbor, MI 48109, USA
Surg Endosc 25:2725-30. 2011....
- Implementation of a small bowel obstruction guideline improves hospital efficiencyWendy L Wahl
Trauma and Surgical Critical Care, Saint Joseph Mercy Ann Arbor, Ann Arbor, MI 48106 0995, USA
Surgery 152:626-32; discussion 632-4. 2012..Concern for potential delays in operation led to formalization of an institution-wide SBO management guideline. We hypothesized that use of the guideline would improve initial triage and patient outcomes...
- Influence of body mass index on complications and oncologic outcomes following hepatectomy for malignancyAmit K Mathur
Division of Transplantation, Department of Surgery, University of Michigan, 2226 Taubman Center, 1500 E Medical Center Drive, Ann Arbor, MI 48109 0331, USA
J Gastrointest Surg 14:849-57. 2010..Following hepatectomy for malignancy, the effect of body mass index (BMI) on hepatic and oncologic outcomes is unknown...
- The Michigan surgical quality collaborative: will a statewide quality improvement initiative pay for itself?Michael J Englesbe
Department of Surgery, University of Michigan, Ann Arbor, MI 48109, USA
Ann Surg 246:1100-3. 2007..quot; The payer has made a significant investment in this regional surgical quality improvement (QI) program and funds each center's participation...
- Does pancreatic duct stenting decrease the rate of pancreatic fistula following pancreaticoduodenectomy? Results of a prospective randomized trialJordan M Winter
Department of Surgery, Johns Hopkins Medical Institutions, Baltimore, Maryland, USA
J Gastrointest Surg 10:1280-90; discussion 1290. 2006..3). Internal pancreatic duct stenting does not decrease the frequency or the severity of postoperative pancreatic fistulas...